Antioxidant effect of MnTE-2-PyP on lung in asthma mice model

Lyudmil Terziev1, Violeta Dancheva, Veneta Shopova

  • 1Sector of Clinical Immunology and Allergology, Pelven Medical University, 5800 Pleven, Bulgaria. luterzi@mail.bg

Abstract

Insights

Manganese TE-2-PyP (MnTE-2-PyP) treatment reduced oxidative stress in a mouse model of asthma. This compound helped restore antioxidant defense system markers in the lungs of asthmatic mice.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Background:

  • Asthma is associated with increased oxidative stress.
  • Antioxidant defense systems are often compromised in asthma.
  • Novel therapeutic strategies targeting oxidative stress are needed for asthma management.

Purpose of the Study:

  • To evaluate the impact of MnTE-2-PyP on antioxidant markers in an ovalbumin-induced asthma mouse model.
  • To determine if MnTE-2-PyP can ameliorate oxidative stress in asthma.

Main Methods:

  • Mice were divided into control, ovalbumin-induced asthma, MnTE-2-PyP treated, and ovalbumin + MnTE-2-PyP treated groups.
  • Lung homogenates were analyzed for superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities, and nonprotein sulfhydryl (NPSH) content.
  • Enzyme activities and NPSH levels were compared across experimental groups.

Main Results:

  • Ovalbumin-induced asthma significantly decreased SOD and CAT activities compared to controls.
  • MnTE-2-PyP treatment in asthmatic mice partially restored SOD and CAT activities.
  • Similar trends were observed for GPx activity and NPSH content, indicating reduced oxidative stress with MnTE-2-PyP application.

Conclusions:

  • MnTE-2-PyP demonstrates a protective effect against oxidative stress in an asthma mouse model.
  • The compound appears to modulate key components of the antioxidant defense system.
  • MnTE-2-PyP shows potential as a therapeutic agent for mitigating oxidative stress in asthma.